{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:44:27Z","timestamp":1794008667628,"version":"4.8.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Haematology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.beha.2022.101376","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T23:05:45Z","timestamp":1661209545000},"page":"101376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Dysregulation of Protein S in COVID-19"],"prefix":"10.1016","volume":"35","author":[{"given":"Martha M.S.","family":"Sim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5487-852X","authenticated-orcid":false,"given":"Jeremy P.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.beha.2022.101376_bib1","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemostasis"},{"issue":"5","key":"10.1016\/j.beha.2022.101376_bib2","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1161\/ATVBAHA.120.312674","article-title":"Recent insights into the regulation of coagulation and thrombosis","volume":"40","author":"Li","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"40","key":"10.1016\/j.beha.2022.101376_bib3","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1021\/bi00492a016","article-title":"Proteolytic activation of human factor IX and factor X by recombinant human factor VIIa - effects of calcium, phospholipids, and tissue factor","volume":"29","author":"Komiyama","year":"1990","journal-title":"Biochemistry"},{"issue":"5091","key":"10.1016\/j.beha.2022.101376_bib4","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/214923a0","article-title":"Relationship between factor V and activated factor X in the generation of prothrombinase","volume":"214","author":"Barton","year":"1967","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.beha.2022.101376_bib5","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1073\/pnas.96.5.2311","article-title":"Blood-borne tissue factor: another view of thrombosis","volume":"96","author":"Giesen","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.beha.2022.101376_bib6","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/jth.13235","article-title":"Contact system revisited: an interface between inflammation, coagulation, and innate immunity","volume":"14","author":"Long","year":"2016","journal-title":"J Thromb Haemostasis"},{"issue":"1","key":"10.1016\/j.beha.2022.101376_bib7","first-page":"90","article-title":"The tale of protein S and C4b-binding protein, a story of affection","volume":"98","author":"Dahlb\u00e4ck","year":"2007","journal-title":"Thromb Haemostasis"},{"issue":"2","key":"10.1016\/j.beha.2022.101376_bib8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1160\/TH12-08-0622","article-title":"Platelet protein S directly inhibits procoagulant activity on platelets and microparticles","volume":"109","author":"Stavenuiter","year":"2013","journal-title":"Thromb Haemostasis"},{"issue":"22","key":"10.1016\/j.beha.2022.101376_bib9","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1182\/blood.2019003630","article-title":"Platelet protein S limits venous but not arterial thrombosis propensity by controlling coagulation in the thrombus","volume":"135","author":"Calzavarini","year":"2020","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.beha.2022.101376_bib10","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1111\/jth.15025","article-title":"Anticoagulant protein S\u2014new insights on interactions and functions","volume":"18","author":"Gierula","year":"2020","journal-title":"J Thromb Haemostasis"},{"issue":"4","key":"10.1016\/j.beha.2022.101376_bib11","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1182\/blood-2003-05-1551","article-title":"Coagulation, inflammation, and apoptosis: different roles for protein S and the protein S-C4b binding protein complex","volume":"103","author":"Rezende","year":"2004","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.beha.2022.101376_bib12","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1016\/S0021-9258(19)70660-7","article-title":"Regulation of activated protein C by a new protein. A possible function for bovine protein S","volume":"255","author":"Walker","year":"1980","journal-title":"J Biol Chem"},{"issue":"21","key":"10.1016\/j.beha.2022.101376_bib13","doi-asserted-by":"crossref","first-page":"11128","DOI":"10.1016\/S0021-9258(19)68566-2","article-title":"Regulation of activated protein C by protein S. The role of phospholipid in factor Va inactivation","volume":"256","author":"Walker","year":"1981","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.beha.2022.101376_bib14","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1172\/JCI113721","article-title":"Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor","volume":"82","author":"Koedam","year":"1988","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.beha.2022.101376_bib15","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1073\/pnas.0504240103","article-title":"Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor","volume":"103","author":"Hackeng","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.beha.2022.101376_bib16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1161\/ATVBAHA.113.302655","article-title":"Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-\u03b1 but not for cell surface\u2013associated tissue factor pathway inhibitor","volume":"34","author":"Wood","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.beha.2022.101376_bib17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/rth2.12057","article-title":"Factor V-short and protein S as synergistic tissue factor pathway inhibitor (TFPI\u03b1) cofactors","volume":"2","author":"Dahlb\u00e4ck","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"issue":"10","key":"10.1016\/j.beha.2022.101376_bib18","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1161\/ATVBAHA.112.250928","article-title":"Inhibition of intrinsic Xase by protein S: a novel regulatory role of protein S independent of activated protein C","volume":"32","author":"Chattopadhyay","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.beha.2022.101376_bib19","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/ATVBAHA.117.310588","article-title":"Anticoagulant protein S targets the factor IXa Heparin-binding exosite to prevent thrombosis","volume":"38","author":"Plautz","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.beha.2022.101376_bib20","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1073\/pnas.78.4.2512","article-title":"High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein","volume":"78","author":"Dahlb\u00e4ck","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"42","key":"10.1016\/j.beha.2022.101376_bib21","doi-asserted-by":"crossref","first-page":"32038","DOI":"10.1074\/jbc.M110.148452","article-title":"Dependence on vitamin K-dependent protein S for eukaryotic cell secretion of the beta-chain of C4b-binding protein","volume":"285","author":"Carlsson","year":"2010","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.beha.2022.101376_bib22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/s-0038-1646373","article-title":"Protein S and C4b-binding protein: components involved in the regulation of the protein C anticoagulant system","volume":"66","author":"Dahlb\u00e4ck","year":"1991","journal-title":"Thromb Haemostasis"},{"issue":"3","key":"10.1016\/j.beha.2022.101376_bib23","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1182\/blood.V84.3.815.815","article-title":"Differential regulation of alpha and beta chains of C4b-binding protein during acute-phase response resulting in stable plasma levels of free anticoagulant protein S","volume":"84","author":"Garc\u00eda de Frutos","year":"1994","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.beha.2022.101376_bib24","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.4049\/jimmunol.169.5.2580","article-title":"Vitamin K-dependent protein S localizing complement regulator C4b-binding protein to the surface of apoptotic cells","volume":"169","author":"Webb","year":"2002","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.beha.2022.101376_bib25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1182\/blood.V81.2.405.405","article-title":"Protein S enhances C4b binding protein interaction with neutrophils","volume":"81","author":"Furmaniak-Kazmierczak","year":"1993","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.beha.2022.101376_bib26","doi-asserted-by":"crossref","first-page":"23869","DOI":"10.1074\/jbc.C400159200","article-title":"The C4b-binding protein-protein S complex inhibits the phagocytosis of apoptotic cells","volume":"279","author":"Kask","year":"2004","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.beha.2022.101376_bib27","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1084\/jem.20050189","article-title":"C4b-binding protein binds to necrotic cells and DNA, limiting DNA release and inhibiting complement activation","volume":"201","author":"Trouw","year":"2005","journal-title":"J Exp Med"},{"issue":"37","key":"10.1016\/j.beha.2022.101376_bib28","doi-asserted-by":"crossref","first-page":"25750","DOI":"10.1074\/jbc.M114.569020","article-title":"Receptor tyrosine kinases, TYRO3, AXL, and MER, demonstrate distinct patterns and complex regulation of ligand-induced activation","volume":"289","author":"Tsou","year":"2014","journal-title":"J Biol Chem"},{"issue":"25","key":"10.1016\/j.beha.2022.101376_bib29","doi-asserted-by":"crossref","first-page":"5073","DOI":"10.1182\/blood-2012-05-429183","article-title":"The vitamin K-dependent anticoagulant factor, protein S, inhibits multiple VEGF-A-induced angiogenesis events in a Mer- and SHP2-dependent manner","volume":"120","author":"Fraineau","year":"2012","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.beha.2022.101376_bib30","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.3892\/ijo.2016.3755","article-title":"Silencing of PROS1 induces apoptosis and inhibits migration and invasion of glioblastoma multiforme cells","volume":"49","author":"Che Mat","year":"2016","journal-title":"Int J Oncol"},{"key":"10.1016\/j.beha.2022.101376_bib31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/bs.ircmb.2020.09.011","article-title":"Immunological role of TAM receptors in the cancer microenvironment","volume":"357","author":"Gadiyar","year":"2020","journal-title":"Int Rev Cell Mol Biol"},{"key":"10.1016\/j.beha.2022.101376_bib32","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejphar.2019.04.039","article-title":"The vitamin K-dependent factor, protein S, regulates brain neural stem cell migration and phagocytic activities towards glioma cells","volume":"855","author":"Ginisty","year":"2019","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.beha.2022.101376_bib33","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.4049\/jimmunol.1601520","article-title":"Efferocytosis signaling in the regulation of macrophage inflammatory responses","volume":"198","author":"Elliott","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.beha.2022.101376_bib34","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3389\/fimmu.2018.00358","article-title":"Macrophage-derived protein S facilitates apoptotic polymorphonuclear cell clearance by resolution phase macrophages and supports their reprogramming","volume":"9","author":"Lumbroso","year":"2018","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.beha.2022.101376_bib35","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1172\/JCI97354","article-title":"Tumor-secreted Pros1 inhibits macrophage M1 polarization to reduce antitumor immune response","volume":"128","author":"Ubil","year":"2018","journal-title":"J Clin Invest"},{"issue":"33","key":"10.1016\/j.beha.2022.101376_bib36","doi-asserted-by":"crossref","first-page":"16513","DOI":"10.1073\/pnas.1821601116","article-title":"STAT6 induces expression of Gas6 in macrophages to clear apoptotic neutrophils and resolve inflammation","volume":"116","author":"Nepal","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beha.2022.101376_bib37","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.virol.2017.12.025","article-title":"Protein S and Gas6 induce efferocytosis of HIV-1-infected cells","volume":"515","author":"Chua","year":"2018","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.beha.2022.101376_bib38","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ajh.21992","article-title":"Protein S abnormalities: a diagnostic nightmare","volume":"86","author":"Marlar","year":"2011","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.beha.2022.101376_bib39","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1111\/j.1365-2516.2008.01775.x","article-title":"Protein S deficiency: a clinical perspective","volume":"14","author":"ten Kate","year":"2008","journal-title":"Haemophilia"},{"issue":"5","key":"10.1016\/j.beha.2022.101376_bib40","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2174\/1389450054545980","article-title":"Protein S and congenital protein S deficiency: the most frequent congenital thrombophilia in Japanese","volume":"6","author":"Adachi","year":"2005","journal-title":"Curr Drug Targets"},{"issue":"1","key":"10.1016\/j.beha.2022.101376_bib41","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/rth2.12058","article-title":"Correlates of plasma and platelet tissue factor pathway inhibitor, factor V, and Protein S","volume":"2","author":"Ellery","year":"2018","journal-title":"Res Pract Thrombosis Haemostasis"},{"issue":"5","key":"10.1016\/j.beha.2022.101376_bib42","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MOH.0000000000000663","article-title":"Protein S: function, regulation, and clinical perspectives","volume":"28","author":"Majumder","year":"2021","journal-title":"Curr Opin Hematol"},{"issue":"7","key":"10.1016\/j.beha.2022.101376_bib43","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1182\/blood.V81.7.1801.1801","article-title":"Protein S deficiency in men with long-term human immunodeficiency virus infection","volume":"81","author":"Stahl","year":"1993","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.beha.2022.101376_bib44","first-page":"484","article-title":"Acquired protein S deficiency: correlation with advanced disease in HIV-1-infected patients","volume":"5","author":"Bissuel","year":"1988","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"10.1016\/j.beha.2022.101376_bib45","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/QAI.0000000000002994","article-title":"Total plasma protein S is a prothrombotic marker in people living with HIV","volume":"90","author":"Sim","year":"2022","journal-title":"JAIDS J Acquir Immune Defic Synd"},{"issue":"3","key":"10.1016\/j.beha.2022.101376_bib46","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/107602960401000311","article-title":"Thrombosis and a hypercoagulable state in HIV-infected patients","volume":"10","author":"Shen","year":"2004","journal-title":"Clin Appl Thrombosis\/Hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis\/Hemostasis."},{"issue":"9","key":"10.1016\/j.beha.2022.101376_bib47","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/BF02190684","article-title":"Varicella and thrombotic complications associated with transient protein C and protein S deficiencies in children","volume":"153","author":"Nguy\u00ean","year":"1994","journal-title":"Eur J Pediatr"},{"issue":"3","key":"10.1016\/j.beha.2022.101376_bib48","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1086\/341410","article-title":"Coagulation abnormalities in dengue Hemorrhagic fever: serial investigations in 167 Vietnamese children with dengue shock syndrome","volume":"35","author":"Wills","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.beha.2022.101376_bib49","first-page":"251","article-title":"Anticoagulant protein S in COVID-19: low activity, and associated with outcome","volume":"58","author":"Stoichitoiu","year":"2020","journal-title":"Rom J Intern Med"},{"issue":"1","key":"10.1016\/j.beha.2022.101376_bib50","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1097\/MJT.0000000000001306","article-title":"Anticoagulant protein S in COVID-19: the low activity level is probably secondary","volume":"28","author":"Baicus","year":"2021","journal-title":"Am J Therapeut"},{"issue":"4","key":"10.1016\/j.beha.2022.101376_bib51","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/rth2.12147","article-title":"In silico thrombin generation: plasma composition imbalance and mortality in human immunodeficiency virus","volume":"2","author":"Brummel\u2010Ziedins","year":"2018","journal-title":"Res Pract Thrombosis Haemostasis"},{"issue":"1","key":"10.1016\/j.beha.2022.101376_bib52","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1089\/108729101460065","article-title":"HIV and thrombosis: a review","volume":"15","author":"Saif","year":"2001","journal-title":"AIDS Patient Care STDS"},{"issue":"4","key":"10.1016\/j.beha.2022.101376_bib53","first-page":"455","article-title":"Correlation of antiphospholipid antibodies and protein S deficiency with thrombosis in HIV-infected men","volume":"5","author":"Hassell","year":"1994","journal-title":"Blood Coagul Fibrinolysis : Int J Thrombosis Hemostasis"},{"issue":"1","key":"10.1016\/j.beha.2022.101376_bib54","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.4102\/sajhivmed.v22i1.1253","article-title":"Derangement of protein S and C4b-binding protein levels as acquired thrombophilia in HIV-infected adult Nigerians","volume":"22","author":"Bello","year":"2021","journal-title":"South Afr J HIV Med"},{"issue":"21","key":"10.1016\/j.beha.2022.101376_bib55","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017773","article-title":"High prevalence of acquired thrombophilia without prognosis value in patients with coronavirus disease 2019","volume":"9","author":"Ferrari","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.beha.2022.101376_bib56","first-page":"276","article-title":"COVID-19 infection and recurrent stroke in young patients with protein S deficiency: a case report","volume":"26","author":"Ali","year":"2021","journal-title":"Neurol"},{"issue":"7","key":"10.1016\/j.beha.2022.101376_bib57","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41577-020-0354-x","article-title":"Blood clots and TAM receptor signalling in COVID-19 pathogenesis","volume":"20","author":"Lemke","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10.1016\/j.beha.2022.101376_bib58","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/ejh.13501","article-title":"COVID-19 coagulopathy: an in-depth analysis of the coagulation system","volume":"105","author":"Mart\u00edn-Rojas","year":"2020","journal-title":"Eur J Haematol"},{"issue":"17","key":"10.1016\/j.beha.2022.101376_bib59","first-page":"9161","article-title":"Imbalance between procoagulant factors and natural coagulation inhibitors contributes to hypercoagulability in the critically ill COVID-19 patient: clinical implications","volume":"24","author":"Voicu","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"12","key":"10.1016\/j.beha.2022.101376_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243604","article-title":"Coagulation profile of COVID-19 patients admitted to the ICU: an exploratory study","volume":"15","author":"Corr\u00eaa","year":"2020","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.beha.2022.101376_bib61","article-title":"A prospective study of specialized coagulation parameters in admitted COVID-19 patients and their correlation with acute respiratory distress syndrome and outcome","volume":"13","author":"Sehgal","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.beha.2022.101376_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.dib.2020.106519","article-title":"Prothrombotic hemostasis disturbances in patients with severe COVID-19: individual daily data","volume":"33","author":"Hardy","year":"2020","journal-title":"Data Brief"},{"issue":"1","key":"10.1016\/j.beha.2022.101376_bib63","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/ijlh.13329","article-title":"Evaluation of COVID-19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays","volume":"43","author":"White","year":"2021","journal-title":"Int J Lab Hematol"},{"issue":"3","key":"10.1016\/j.beha.2022.101376_bib64","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s11239-021-02575-4","article-title":"Global haemostatic tests demonstrate the absence of parameters of hypercoagulability in non-hypoxic mild COVID-19 patients: a prospective matched study","volume":"53","author":"Fan","year":"2022","journal-title":"J Thromb Thrombolysis"},{"issue":"1","key":"10.1016\/j.beha.2022.101376_bib65","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1055\/s-0040-1722612","article-title":"A matter of caution: coagulation parameters in COVID-19 do not differ from patients with ruled-out SARS-CoV-2 infection in the emergency department","volume":"5","author":"Bauer","year":"2021","journal-title":"TH open : companion journal to thrombosis and haemostasis"},{"issue":"12","key":"10.1016\/j.beha.2022.101376_bib66","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/crj.13438","article-title":"COVID-19 and coagulopathy","volume":"15","author":"Sarkar","year":"2021","journal-title":"Clin Res J"},{"issue":"6","key":"10.1016\/j.beha.2022.101376_bib67","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/MOH.0000000000000666","article-title":"Mechanisms of immunothrombosis in COVID-19","volume":"28","author":"Portier","year":"2021","journal-title":"Curr Opin Hematol"},{"issue":"Suppl 1","key":"10.1016\/j.beha.2022.101376_bib68","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/ijlh.13547","article-title":"COVID-19-related laboratory coagulation findings","volume":"43","author":"Devreese","year":"2021","journal-title":"Int J Lab Hematol"},{"issue":"4","key":"10.1016\/j.beha.2022.101376_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9040335","article-title":"Growth arrest-specific factor 6 (GAS6) is increased in COVID-19 patients and predicts clinical outcome","volume":"9","author":"Morales","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.beha.2022.101376_bib70","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1568352","article-title":"Baseline plasma Gas6 protein elevation predicts adverse outcomes in hospitalized COVID-19 patients","author":"Tonello","year":"2022","journal-title":"Dis Markers"},{"issue":"10","key":"10.1016\/j.beha.2022.101376_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/cells9102186","article-title":"Role of vitamin K-dependent factors protein S and GAS6 and TAM receptors in SARS-CoV-2 infection and COVID-19-associated immunothrombosis","volume":"9","author":"Tutusaus","year":"2020","journal-title":"Cells"},{"issue":"59","key":"10.1016\/j.beha.2022.101376_bib72","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abh2259","article-title":"Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection","volume":"6","author":"Ma","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.beha.2022.101376_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.714511","article-title":"Lectin pathway mediates complement activation by SARS-CoV-2 proteins","volume":"12","author":"Ali","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.beha.2022.101376_bib74","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jaci.2020.05.006","article-title":"Complement activation in patients with COVID-19: a novel therapeutic target","volume":"146","author":"Cugno","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"7836","key":"10.1016\/j.beha.2022.101376_bib75","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41586-020-2600-6","article-title":"Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis","volume":"588","author":"Carvelli","year":"2020","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.beha.2022.101376_bib76","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1172\/JCI141374","article-title":"Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis","volume":"130","author":"Skendros","year":"2020","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.beha.2022.101376_bib77","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1055\/s-0038-1655974","article-title":"C5a induces tissue factor activity on endothelial cells","volume":"77","author":"Ikeda","year":"1997","journal-title":"Thromb Haemostasis"},{"issue":"10","key":"10.1016\/j.beha.2022.101376_bib78","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/s41591-020-1021-2","article-title":"Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection","volume":"26","author":"Ramlall","year":"2020","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.beha.2022.101376_bib79","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1021\/acsinfecdis.0c00866","article-title":"The SARS-CoV-2 SSHHPS recognized by the papain-like protease","volume":"7","author":"Reynolds","year":"2021","journal-title":"ACS Infect Dis"},{"issue":"7835","key":"10.1016\/j.beha.2022.101376_bib80","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-020-2601-5","article-title":"Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity","volume":"587","author":"Shin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.beha.2022.101376_bib81","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.thromres.2020.09.007","article-title":"Identification of the antithrombotic protein S as a potential target of the SARS-CoV-2 papain-like protease","volume":"196","author":"Ruzicka","year":"2020","journal-title":"Thromb Res"},{"issue":"570","key":"10.1016\/j.beha.2022.101376_bib82","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd3876","article-title":"Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19","volume":"12","author":"Zuo","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.beha.2022.101376_bib83","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cytogfr.2021.05.001","article-title":"Antiphospholipid antibodies and risk of post-COVID-19 vaccination thrombophilia: the straw that breaks the camel's back?","volume":"60","author":"Talotta","year":"2021","journal-title":"Cytokine Growth Factor Rev"},{"issue":"10","key":"10.1016\/j.beha.2022.101376_bib84","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1182\/blood.V81.10.2618.2618","article-title":"Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism?","volume":"81","author":"Oosting","year":"1993","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.beha.2022.101376_bib85","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1182\/blood-2018-04-841585","article-title":"Hypoxia downregulates protein S expression","volume":"132","author":"Pilli","year":"2018","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.beha.2022.101376_bib86","doi-asserted-by":"crossref","first-page":"15954","DOI":"10.18632\/aging.103869","article-title":"COVID-19: a probable role of the anticoagulant Protein S in managing COVID-19-associated coagulopathy","volume":"12","author":"Chatterjee","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.beha.2022.101376_bib87","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.64330","article-title":"SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung","volume":"10","author":"Mast","year":"2021","journal-title":"Elife"},{"issue":"11","key":"10.1016\/j.beha.2022.101376_bib88","doi-asserted-by":"crossref","first-page":"e4039","DOI":"10.1093\/cid\/ciaa1258","article-title":"Reduced vitamin K status as a potentially modifiable risk factor of severe coronavirus disease 2019","volume":"73","author":"Dofferhoff","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.beha.2022.101376_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110218","article-title":"Vitamin K epoxide reductase complex subunit 1 (VKORC1) gene polymorphism as determinant of differences in Covid-19-related disease severity","volume":"144","author":"Janssen","year":"2020","journal-title":"Med Hypotheses"},{"issue":"2","key":"10.1016\/j.beha.2022.101376_bib90","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1017\/S0007114520003979","article-title":"Vitamin K metabolism as the potential missing link between lung damage and thromboembolism in Coronavirus disease 2019","volume":"126","author":"Janssen","year":"2021","journal-title":"Br J Nutr"},{"key":"10.1016\/j.beha.2022.101376_bib91","article-title":"HIV-1 and SARS-CoV-2 both cause protein S, but through different mechanisms [abstract]","volume":"5","author":"Sim","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"issue":"5","key":"10.1016\/j.beha.2022.101376_bib92","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/ccr3.1464","article-title":"High protein S activity due to C4b-binding protein deficiency in a 34-year-old Surinamese female with ischemic retinopathy","volume":"6","author":"Mulder","year":"2018","journal-title":"Clin Case Rep"}],"container-title":["Best Practice & Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692622000317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692622000317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:07:45Z","timestamp":1761498465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692622000317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":92,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1521692622000317"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2022.101376","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysregulation of Protein S in COVID-19","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Haematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beha.2022.101376","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101376"}}